A in vivo study on pre-operative biopsy and post-irradiation specimens in 98 patients of rectal cancer involving human cancer patients found that increased GHR expression level was associated with poor response to radiation treatment, suggesting that GHR-antagonism can actually improve rectal cancer sensitivity to radiotherapy (Wu et al., 2006). The gene discussed is GHR; the disease is rectal cancer.